List of Actelion patents

Patents where

Current Assignee

Name

Actelion

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11464777 Pharmaceutical composition for the treatment of pulmonary arterial hypertension		Actelion	Actelion	United States Patent and Trademark Office	11464777	October 11, 2022
‌ US Patent D974921 Pharmaceutical package	Patent D974921 was granted and assigned to Actelion on January, 2023 by the United States Patent and Trademark Office.	Actelion	Actelion	United States Patent and Trademark Office	D974921	January 10, 2023
‌ US Patent 8003800 Thiophene derivatives as S1P1/EDG1 receptor agonists	Patent 8003800 was granted and assigned to Actelion on August, 2011 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8003800	August 23, 2011
‌ US Patent 7544691 Guanidine derivatives	Patent 7544691 was granted and assigned to Actelion on June, 2009 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7544691	June 9, 2009
‌ US Patent 8709734 Method for identifying modulators of GPCR GPR1 function	Patent 8709734 was granted and assigned to Actelion on April, 2014 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8709734	April 29, 2014
‌ US Patent 7538109 Quinoxalin-3-one derivatives as orexin receptor antagonists	Patent 7538109 was granted and assigned to Actelion on May, 2009 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7538109	May 26, 2009
‌ US Patent 7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases	Patent 7427613 was granted and assigned to Actelion on September, 2008 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7427613	September 23, 2008
‌ US Patent 7285549 Sulfamides and their use as endothelin receptor antagonists	Patent 7285549 was granted and assigned to Actelion on October, 2007 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7285549	October 23, 2007
‌ US Patent 8658675 Pyridin-4-yl derivatives	Patent 8658675 was granted and assigned to Actelion on February, 2014 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8658675	February 25, 2014
‌ US Patent 7452896 Pyrimidine-sulfamides and their use as endothelian receptor antagonist	Patent 7452896 was granted and assigned to Actelion on November, 2008 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7452896	November 18, 2008
‌ US Patent 7626037 Thiazolidin-4-one derivatives	Patent 7626037 was granted and assigned to Actelion on December, 2009 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7626037	December 1, 2009
‌ US Patent 9617250 Pyridin-4-yl derivatives	Patent 9617250 was granted and assigned to Actelion on April, 2017 by the United States Patent and Trademark Office.	Actelion	Actelion	United States Patent and Trademark Office	9617250	April 11, 2017
‌ US Patent 7605269 Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists	Patent 7605269 was granted and assigned to Actelion on October, 2009 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7605269	October 20, 2009
‌ US Patent 8193179 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives	Patent 8193179 was granted and assigned to Actelion on June, 2012 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8193179	June 5, 2012
‌ US Patent 7846964 Thiophene derivatives as spingosine-1-phosphate-1 receptor agonists	Patent 7846964 was granted and assigned to Actelion on December, 2010 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7846964	December 7, 2010
‌ US Patent 8697732 Pyridine derivatives	Patent 8697732 was granted and assigned to Actelion on April, 2014 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8697732	April 15, 2014
‌ US Patent 8044076 Phenyl derivatives and their use as immunomodulators	Patent 8044076 was granted and assigned to Actelion on October, 2011 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8044076	October 25, 2011
‌ US Patent 7951794 Thiophene derivatives	Patent 7951794 was granted and assigned to Actelion on May, 2011 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7951794	May 31, 2011
‌ US Patent 10220023 Dosing regimen for a selective S1P	Patent 10220023 was granted and assigned to Actelion on March, 2019 by the United States Patent and Trademark Office.	Actelion	Actelion	United States Patent and Trademark Office	10220023	March 5, 2019
‌ US Patent 11648249 Stable pharmaceutical compositions comprising a pyrimidine-sulfamide	Patent 11648249 was granted and assigned to Actelion on May, 2023 by the United States Patent and Trademark Office.	Actelion	Actelion	United States Patent and Trademark Office	11648249	May 16, 2023
‌ US Patent 7968720 Secondary amines as renin inhibitors	Patent 7968720 was granted and assigned to Actelion on June, 2011 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	7968720	June 28, 2011
‌ US Patent 9221832 Heterocyclic amide derivatives as P2X7 receptor antagonists	Patent 9221832 was granted and assigned to Actelion on December, 2015 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	9221832	December 29, 2015
‌ US Patent 8247560 Trisubstituted 3,4-dihydro-1H-isoquinolin compound, process for its preparation, and its use	Patent 8247560 was granted and assigned to Actelion on August, 2012 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8247560	August 21, 2012
‌ US Patent 8133910 Thiophene derivatives as S1P1/EDGE1 receptor agonists	Patent 8133910 was granted and assigned to Actelion on March, 2012 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8133910	March 13, 2012
‌ US Patent 8148410 Thiophene derivatives as agonists of S1P1/EDG1	Patent 8148410 was granted and assigned to Actelion on April, 2012 by the United States Patent and Trademark Office.		Actelion	United States Patent and Trademark Office	8148410	April 3, 2012

...

Results per page:

195 results

0 selected

195 results

0 selected